About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in New York | 6,696 Studies Near You

Clinical TrialsNew York

Clinical Trials in New York

Discover 6,696 clinical trials near New York, New York. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 321-340 of 6,696 trials

CompletedPexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)During a heart bypass procedure, a substance called "complement" is activated by the body.NCT00088179·Birmingham, Alabama and 187 others

Find Trials by Condition in New York

Breast Cancerin New York Lung Cancerin New York Prostate Cancerin New York Colorectal Cancerin New York Melanomain New York Leukemiain New York Lymphomain New York Pancreatic Cancerin New York Ovarian Cancerin New York Brain Cancerin New York Diabetes

Data from ClinicalTrials.govTerms

CompletedThe Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy TrialThis study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or stroke) in people with coronary heart disease.NCT00799903·Birmingham, Alabama and 649 others

Active not recruitingStudy Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal TreatmentThe purpose of this study is to evaluate the efficacy and safety of \[Lu-177\]-PNT2002 in patients with metastatic castration-resistant prostate cancer who have progressed…NCT04647526·Tucson, Arizona and 53 others

CompletedSafety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior UveitisThe purpose of this study is to define a safe and effective dose of iontophoretic delivery of dexamethasone phosphate ophthalmic solution using the EyeGate® II Drug Delivery…NCT00694135·Miami, Florida and 18 others

CompletedInvestigation of the Role of Steroids in Enhancing Voice Therapy OutcomesDespite the considerable use of oral steroids in the regular management of benign vocal fold lesions there is little evidence base in the literature.NCT02286960·New York, New York

CompletedLeft Versus Right Radial Artery and Radiation Exposure in Patients With Predictors of Trans-radial FailureThe aim of this study is to measure radiation exposure during coronary angiography (CA) with a trans-radial approach (TRA), specifically comparing access via the left versus right…NCT01707524·New York, New York

CompletedRituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00274924·Palo Alto, California and 103 others

CompletedStudy of TPI 287 in Patients With Advanced MalignanciesTapestry Pharmaceuticals, Inc. has developed a novel taxane analog, TPI 287.NCT00113724·Tucson, Arizona and 3 others

CompletedPilot Study of Atorvastatin for Orthopedic Surgery PatientsUp to 35% of hip fracture patients have been shown to experience heart injury after surgery, and as many as 10% have a heart attack or die in the three months after surgery.NCT02197065·New York, New York and 1 other

CompletedNeuropsychological and Behavioral Testing in Younger Patients With CancerThis research trial studies neuropsychological (learning, remembering or thinking) and behavioral outcomes in children and adolescents with cancer by collecting information over…NCT00772200·Birmingham, Alabama and 183 others

CompletedA Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular EdemaThis study will evaluate the efficacy, safety, and pharmacokinetics of faricimab administered at 8-week intervals or as specified in the protocol following treatment initiation…NCT03622593·Phoenix, Arizona and 187 others

RecruitingGEMINI-NSCLC: NSCLC Biomarker StudyGEMINI NSCLC Study is a non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal blood…NCT05236114·Birmingham, Alabama and 57 others

Active not recruitingA Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular LymphomaB-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections).NCT05451810·Mobile, Alabama and 71 others

CompletedEffectiveness of BufferGel as a Vaginal ContraceptiveBufferGel is a new contraceptive gel designed to be used with a diaphragm.NCT00065858·Berkeley, California and 8 others

CompletedOral Anticoagulant Apixaban for Treatment of Venous ThromboembolismPatients who have developed a venous thrombosis will receive apixaban to treat and prevent a secondary thromboembolism.NCT04041843·Valhalla, New York

CompletedOnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive BladderThis is a study to evaluate the efficacy and safety of onabotulinumtoxinA (BOTOX®) compared with placebo, in achieving a 100% reduction in urinary incontinence in patients with…NCT01945489·Huntsville, Alabama and 39 others

RecruitingA Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTThis phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with…NCT04684368·Birmingham, Alabama and 169 others

CompletedGlutamate Reducing Interventions in SchizophreniaParticipants will be administered several doses of pomaglumetad (POMA) (low and high doses) over 14 days to individuals at clinical high risk for developing psychosis and use…NCT03321617·New York, New York

CompletedSafety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent ClaudicationThe purpose of this Phase 2 clinical research study is to examine the safety of an experimental gene transfer agent, Ad2/HIF-1α/VP16, and its ability to stimulate the growth of…NCT00117650·Birmingham, Alabama and 46 others

RecruitingEfficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary HemochromatosisThis is a phase 2, multicenter, randomized, placebo-controlled, double-blind, parallel-group, proof-of-concept study to assess vamifeport in adult participants with homeostatic…NCT07332091·Gilbert, Arizona and 99 others

PreviousPage 17 of 335Next

in New York

Heart Diseasein New York